SLE-DAS in the First Trimester of Gestation Predicts Maternal Lupus Flares Later in Pregnancy
Conclusions: SLE-DAS was highly correlated with SLEPDAI and its use in the first trimester predicted maternal flares in the 2nd and 3rd trimester, making SLE-DAS a reliable instrument to measure SLE activity during pregnancy.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Drugs & Pharmacology | France Health | Italy Health | Lupus | OBGYN | Perinatology & Neonatology | Pregnancy | Women